Monte Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-52,026
| Closed | -$3.03M | – | 63 |
|
|
2020
Q4 | $3.03M | Sell |
52,026
-3,506
| -6% | -$204K | 2.06% | 31 |
|
|
2020
Q3 | $3.51M | Buy |
55,532
+4,381
| +9% | +$277K | 2.65% | 14 |
|
|
2020
Q2 | $3.94M | Buy |
51,151
+3,324
| +7% | +$256K | 3.11% | 8 |
|
|
2020
Q1 | $3.58M | Sell |
47,827
-14,164
| -23% | -$1.06M | 3.46% | 2 |
|
|
2019
Q4 | $4.03M | Buy |
61,991
+6,558
| +12% | +$426K | 2.97% | 6 |
|
|
2019
Q3 | $3.51M | Buy |
55,433
+2,154
| +4% | +$137K | 2.83% | 10 |
|
|
2019
Q2 | $3.6M | Buy |
53,279
+3,042
| +6% | +$206K | 3.05% | 6 |
|
|
2019
Q1 | $3.27M | Buy |
50,237
+6,139
| +14% | +$399K | 2.86% | 13 |
|
|
2018
Q4 | $2.76M | Buy |
44,098
+960
| +2% | +$60K | 2.92% | 13 |
|
|
2018
Q3 | $3.33M | Buy |
43,138
+3,569
| +9% | +$276K | 3.12% | 9 |
|
|
2018
Q2 | $2.8M | Buy |
39,569
+1,877
| +5% | +$133K | 2.85% | 13 |
|
|
2018
Q1 | $2.84M | Buy |
37,692
+1,558
| +4% | +$117K | 2.97% | 11 |
|
|
2017
Q4 | $2.59M | Buy |
+36,134
| New | +$2.59M | 2.63% | 15 |
|